Bradley L. Campbell

Companies

• Amicus TherapeuticsChief executive officer Aug 3, 2022 to now¹
• Amicus TherapeuticsPresident Aug 3, 2022 to now¹
• Amicus TherapeuticsBoard member Jan 10, 2019 to now²
• Amicus TherapeuticsChief operating officer Jun 30, 2014 to Jul 6, 2022³
• Nautilus Biotechnology, Inc.Board member Aug 6, 2020 to Aug 6, 2020⁴
• Amicus TherapeuticsVP, Business Development May 30, 2007 to Apr 11, 2014⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Amicus Therapeutics FOLD0 shares⁶Apr 27, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 27, 2026Returned to company 1,008,680 shares at $14.50 of Amicus Therapeutics⁶
• Mar 2, 2026Sold 22,500 shares at $14.35 of Amicus Therapeutics⁷
• Jan 20, 2026Sold 75,000 shares at $14.31 of Amicus Therapeutics⁸
• Jan 20, 2026Exercised options 75,000 shares at $6.10 of Amicus Therapeutics⁸
• Dec 26, 2025Shares withheld for tax 108,602 shares at $14.25 of Amicus Therapeutics⁹
• Dec 15, 2025Sold 77,926 shares at $10.86 of Amicus Therapeutics¹⁰
• Dec 15, 2025Exercised options 70,426 shares at $9.03 of Amicus Therapeutics¹⁰
• Dec 1, 2025Sold 14,587 shares at $10.01 of Amicus Therapeutics¹¹
• Dec 1, 2025Exercised options 14,587 shares at $9.03 of Amicus Therapeutics¹¹
• Nov 24, 2025Sold 14,587 shares at $10.04 of Amicus Therapeutics¹²
• Nov 24, 2025Exercised options 14,587 shares at $9.03 of Amicus Therapeutics¹²
• Mar 15, 2025Shares withheld for tax 13,375 shares at $8.90 of Amicus Therapeutics¹³
• Feb 19, 2025Sold 400 shares at $10.00 of Amicus Therapeutics¹⁴
• Feb 19, 2025Exercised options 400 shares at $9.03 of Amicus Therapeutics¹⁴
• Feb 11, 2025Shares withheld for tax 70,711 shares at $9.57 of Amicus Therapeutics¹⁵
• Feb 11, 2025Granted 137,075 shares of Amicus Therapeutics¹⁵
• Jan 4, 2025Shares withheld for tax 7,368 shares at $9.41 of Amicus Therapeutics¹⁶
• Jan 3, 2025Shares withheld for tax 41,474 shares at $9.41 of Amicus Therapeutics¹⁶
• Jan 3, 2025Granted 266,528 shares of Amicus Therapeutics¹⁶
• Jan 2, 2025Shares withheld for tax 20,647 shares at $9.31 of Amicus Therapeutics¹⁶
• Dec 2, 2024Sold 7,500 shares at $10.02 of Amicus Therapeutics¹⁷
• Dec 2, 2024Exercised options 7,500 shares at $8.61 of Amicus Therapeutics¹⁷
• Nov 6, 2024Sold 7,901 shares at $12.50 of Amicus Therapeutics¹⁸
• Nov 6, 2024Exercised options 7,901 shares at $12.28 of Amicus Therapeutics¹⁸
• Nov 1, 2024Sold 7,500 shares at $11.46 of Amicus Therapeutics¹⁹